Wetmore N E, Bartlett R H, Gazzaniga A B, Haiduc N J
Heart Lung. 1979 Mar-Apr;8(2):288-95.
ECMO may be used clinically in selected cases to provide life support when all other modes of therapy have been exhausted. Survival of moribund patients has been demonstrated. Results might be improved if the severity of the disease is recognized and defined early in the clinical course to prevent the development of irreversible complications. ECMO requires a large, fully trained team to interface with the attending physicians and nursing staff in providing complete life support. The ECMO team provides continued evaluation of the status and treatment of the patient, detection of complications, and correction of any minor or major emergency. It also conducts laboratory and clinical research programs in pulmonary insufficiency as an adjunct to clinical life-support research.
在所有其他治疗方式均已用尽时,体外膜肺氧合(ECMO)可用于某些特定临床病例以提供生命支持。已证实垂危患者可存活。如果在临床病程早期识别并界定疾病的严重程度以防止出现不可逆并发症,结果可能会得到改善。ECMO需要一个庞大的、训练有素的团队,以便在提供全面生命支持方面与主治医生和护理人员协作。ECMO团队持续评估患者的状况和治疗情况,检测并发症,并纠正任何大小紧急情况。它还开展肺功能不全方面的实验室和临床研究项目,作为临床生命支持研究的辅助。